CooperCompanies will announce Q1 2025 financial results on March 6, followed by a conference call at 5:00 PM ET.
Quiver AI Summary
CooperCompanies announced it will release its first quarter 2025 financial results on March 6, 2025, at 4:15 PM ET, followed by a conference call at 5:00 PM ET to discuss the results and corporate developments. Participants can join the call by dialing 800-715-9871 with the conference ID 7466264, and an audio webcast will also be available on their investor website. CooperCompanies operates globally through its CooperVision and CooperSurgical divisions, focusing on vision care and women's health, respectively. Headquartered in San Ramon, California, the company employs over 16,000 people, serves more than 130 countries, and positively impacts over fifty million lives annually.
Potential Positives
- CooperCompanies is scheduled to report its first quarter 2025 financial results, indicating a commitment to transparency and communication with investors.
- The upcoming conference call provides an opportunity for stakeholders to gain insights into the company's performance and future plans.
- The company’s strong global presence is highlighted by its operation in over 130 countries and a positive impact on more than fifty million lives each year, reinforcing its market leadership and social responsibility.
Potential Negatives
- Announcement of financial results typically follows a quarter of financial performance that could show negative trends, potentially signaling underperformance.
FAQ
When will CooperCompanies report its first quarter 2025 financial results?
CooperCompanies will report its first quarter 2025 financial results on Thursday, March 6, 2025, at 4:15 PM ET.
How can I listen to the CooperCompanies earnings call?
The earnings call will be accessible by dialing 800-715-9871 with the conference ID 7466264, or via audio webcast at http://investor.coopercos.com.
What are the main business units of CooperCompanies?
CooperCompanies operates two main business units: CooperVision, specializing in contact lenses, and CooperSurgical, focusing on fertility and women's healthcare.
Where is CooperCompanies headquartered?
CooperCompanies is headquartered in San Ramon, California.
How many lives does CooperCompanies impact annually?
CooperCompanies positively impacts over fifty million lives each year through its various products and services.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$COO Insider Trading Activity
$COO insiders have traded $COO stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $COO stock by insiders over the last 6 months:
- ALBERT G III WHITE (President & CEO) has made 0 purchases and 2 sales selling 114,992 shares for an estimated $12,710,040.
- DANIEL G MCBRIDE (EVP & Chief Operating Officer) has made 0 purchases and 3 sales selling 114,992 shares for an estimated $12,129,910.
- BRIAN G ANDREWS (EVP, CFO & Treasurer) sold 24,788 shares for an estimated $2,625,071
- AGOSTINO RICUPATI (SVP & CAO) sold 1,601 shares for an estimated $172,955
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$COO Hedge Fund Activity
We have seen 289 institutional investors add shares of $COO stock to their portfolio, and 322 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 1,670,766 shares (+362.6%) to their portfolio in Q3 2024, for an estimated $184,352,320
- MARSHALL WACE, LLP added 1,333,728 shares (+170.1%) to their portfolio in Q3 2024, for an estimated $147,163,547
- FIL LTD removed 1,282,723 shares (-77.2%) from their portfolio in Q3 2024, for an estimated $141,535,655
- MACQUARIE GROUP LTD removed 1,142,608 shares (-42.9%) from their portfolio in Q3 2024, for an estimated $126,075,366
- INVESCO LTD. added 880,578 shares (+21.4%) to their portfolio in Q3 2024, for an estimated $97,162,976
- AMUNDI removed 763,940 shares (-39.1%) from their portfolio in Q3 2024, for an estimated $84,293,139
- POINT72 ASSET MANAGEMENT, L.P. removed 749,175 shares (-79.9%) from their portfolio in Q3 2024, for an estimated $82,663,969
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SAN RAMON, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report first quarter 2025 financial results on Thursday, March 6, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The dial-in number for the call is 800-715-9871 and the conference ID is 7466264. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com .
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 16,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit
www.coopercos.com
.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
[email protected]